The Clorox Company (NYSE:CLX) Receives $103.40 Average Price Target from Analysts

Shares of The Clorox Company (NYSE:CLX) have earned a consensus rating of “Reduce” from the seventeen research firms that are covering the firm, MarketBeat reports. Five analysts have rated the stock with a sell rating, eleven have assigned a hold rating and one has given a buy rating to the company. The average 12 month price target among brokerages that have updated their coverage on the stock in the last year is $103.40.

A number of brokerages recently weighed in on CLX. UBS Group cut their price target on shares of Clorox from $110.00 to $96.00 and set a “neutral” rating on the stock in a report on Friday, May 1st. Jefferies Financial Group decreased their price objective on shares of Clorox from $139.00 to $125.00 and set a “buy” rating for the company in a report on Monday, May 4th. Royal Bank Of Canada dropped their target price on shares of Clorox from $132.00 to $127.00 and set a “sector perform” rating on the stock in a research note on Thursday, April 9th. Morgan Stanley reduced their target price on shares of Clorox from $110.00 to $97.00 and set an “equal weight” rating for the company in a research report on Friday, May 1st. Finally, Deutsche Bank Aktiengesellschaft restated a “hold” rating and set a $91.00 price target on shares of Clorox in a research note on Friday, May 1st.

Insiders Place Their Bets

In other news, Director Pierre R. Breber bought 5,000 shares of the firm’s stock in a transaction on Tuesday, May 5th. The stock was acquired at an average cost of $85.82 per share, with a total value of $429,100.00. Following the completion of the transaction, the director directly owned 18,000 shares of the company’s stock, valued at $1,544,760. This represents a 38.46% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Company insiders own 0.63% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in CLX. State Street Corp boosted its position in Clorox by 3.5% during the third quarter. State Street Corp now owns 8,434,277 shares of the company’s stock worth $1,039,946,000 after purchasing an additional 282,794 shares during the period. Invesco Ltd. raised its position in shares of Clorox by 22.1% in the fourth quarter. Invesco Ltd. now owns 4,880,341 shares of the company’s stock valued at $492,085,000 after purchasing an additional 884,751 shares during the period. Geode Capital Management LLC lifted its stake in shares of Clorox by 0.3% during the 4th quarter. Geode Capital Management LLC now owns 3,172,233 shares of the company’s stock valued at $318,613,000 after buying an additional 10,060 shares in the last quarter. Van ECK Associates Corp boosted its holdings in Clorox by 15.7% in the 4th quarter. Van ECK Associates Corp now owns 3,136,405 shares of the company’s stock worth $316,244,000 after buying an additional 426,433 shares during the period. Finally, Two Sigma Investments LP boosted its holdings in Clorox by 33.8% in the 3rd quarter. Two Sigma Investments LP now owns 1,740,175 shares of the company’s stock worth $214,564,000 after buying an additional 439,797 shares during the period. Institutional investors own 78.53% of the company’s stock.

Clorox Stock Performance

CLX stock opened at $96.57 on Monday. The firm has a market cap of $11.68 billion, a PE ratio of 15.68, a P/E/G ratio of 0.46 and a beta of 0.54. The company has a quick ratio of 0.65, a current ratio of 0.84 and a debt-to-equity ratio of 27.03. The business has a 50 day moving average of $94.10 and a 200-day moving average of $104.11. Clorox has a 12-month low of $84.70 and a 12-month high of $132.03.

Clorox (NYSE:CLX) last posted its quarterly earnings data on Thursday, April 30th. The company reported $1.64 earnings per share for the quarter, topping the consensus estimate of $1.55 by $0.09. Clorox had a return on equity of 443.64% and a net margin of 11.18%.The business had revenue of $1.67 billion for the quarter, compared to analysts’ expectations of $1.67 billion. During the same quarter in the previous year, the firm earned $1.45 earnings per share. The business’s revenue was up .1% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. As a group, sell-side analysts expect that Clorox will post 5.53 earnings per share for the current year.

Clorox Company Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.